Eremothecium coryli bloodstream infection in a patient with acute myeloid leukemia: first case report of human infection.

Antifungal Agents / pharmacology Blood Culture DNA, Fungal / genetics Eremothecium / cytology Female Fungemia / diagnosis Humans Leukemia, Myeloid, Acute / complications Microbial Sensitivity Tests RNA, Ribosomal, 28S / genetics Sequence Analysis, DNA Treatment Failure
28S rRNA sequencing Eremothecium coryli Fungal infection Fungal sequencing Fungemia Saccharomyces

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 27 11 2018
revised: 11 03 2019
accepted: 22 03 2019
pubmed: 22 4 2019
medline: 18 12 2019
entrez: 22 4 2019
Statut: ppublish

Résumé

Eremothecium coryli is a dimorphic fungus of the Saccharomycetes class. While species within this class are known to cause human infection, Eremothecium species have previously only been known as phytopathogens and never been isolated from a human sample. Here, we report the first known case of human E. coryli infection.

Identifiants

DOI: 10.1016/j.diagmicrobio.2019.03.011 PMID: 31005402
pubmed: 31005402
pii: S0732-8893(18)30685-0
doi: 10.1016/j.diagmicrobio.2019.03.011
pii:
doi:

Substances chimiques

Antifungal Agents 0
DNA, Fungal 0
RNA, Ribosomal, 28S 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-79

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Ashrit Multani (A)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: amultani@stanford.edu.

Arjun Rustagi (A)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

David J Epstein (DJ)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Carlos A Gomez (CA)

Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

Indre Budvytiene (I)

Clinical Microbiology Laboratory, Stanford University Medical Center, Palo Alto, CA, USA.

Niaz Banaei (N)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Clinical Microbiology Laboratory, Stanford University Medical Center, Palo Alto, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Janice M Brown (JM)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Anne Y Liu (AY)

Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Techniques microbiologiques › Hémoculture › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ADN › ADN fongique › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Eremothecium › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Sepsie › Fongémie › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Leucémies › Leucémie myéloïde › Leucémie aigüe myéloïde › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 28S › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Eremothecium coryli bloodstream infection in a...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Échec thérapeutique › Eremothecium coryli bloodstream infection in a...